http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006008009-A3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e04826845acea4cc4cdeafc4c2b1e313 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0ef5c3365be7092a20772a4b3afd553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d41ec0461f1dcf5db85678f027758111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d1596f64ec0b2dac5334b2cf05b88bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d37eb461745b8d691065349d29825942 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 |
filingDate | 2005-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fa644991af26b2ab32246087c7e7d0d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fdf74c1bcb0c1a90b3bafcf1461d4cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_065163eea113d79135e234e55d45e2a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2310f9aff201276f5c535b04d852157d |
publicationDate | 2006-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2006008009-A3 |
titleOfInvention | Diagnostics and therapeutics for diseases associated with leucine-rich repeat-containing gpcr 6 (lgr6) |
abstract | The invention provides a human LGR6 which is associated with the cardiovascular disorders, endocrine system and hormone disorders, metabolic diseases, hematological disorders, respiratory diseases, inflammatory diseases, neurological disorders, reproduction disorders, cancer disorders and urological disorders. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular disorders, endocrine system and hormone disorders, metabolic diseases, hematological disorders, respiratory diseases, inflammatory diseases, neurological disorders, reproduction disorders, cancer disorders and urological disorders. The invention also features compounds which bind to and/or activate or inhibit the activity of LGR6 as well as pharmaceutical compositions comprising such compounds. |
priorityDate | 2004-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.